Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Sustained Benefit of Erenumab in Adult Episodic Migraine Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03927144
Recruitment Status : Active, not recruiting
First Posted : April 25, 2019
Last Update Posted : July 15, 2021
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 7, 2021
Estimated Study Completion Date : October 7, 2022